French and U.S. Physicians Say a Simple, Point-of-Care System for Concentrating Autologous Adult Stem Cells From Bone Marrow Is Enabling European Clinicians to Offer New Therapies for a Variety of Serious Diseases, With No Reported Side Effects
17th Nov 2006, 04:30 GMT
Harvest Technologies Corp. (www.harvesttech.com) announced today that a French and a U.S. physician told an audience of other physicians, medical industry executives and patients about a simple, point-of-care...
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- PuriCore Plc announces Appointment
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL